Fighting Cancer

Every Step of the Way

Vigilant Biosciences is transforming the early detection and intervention of cancer.

Learn More
vb-homepage-image3

Dedicated to Early Intervention. And Life.


Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection and intervention of cancer. Its OncAlert™ Oral Cancer Risk Assessment System uses patented technology that is highly-accurate and specific.

Learn More
Did You Know?

When diagnosed early, oral cancer patients have an 80 to 90% survival rate.

Unfortunately, over 40% of those diagnosed with oral cancer will die within five years due to these cases being discovered as a late stage malignancy.

Learn More

At A Glance

Transforming Early Detection

Vigilant Biosciences’ products are based on patented technology that detects specific protein markers known to clinically show elevated risk for early stage cancers, even prior to observation of visual or physical symptoms... more


Easy-to-Use and Non-Invasive

OncAlert™ products utilize a simple oral rinse procedure that is easy to administer and non-invasive for the patient... more


Accurate and Objective Results at the Point-of-Care or Lab

Both the rapid point-of-care test and the lab assay that comprise the OncAlert™ system provide a timely, accurate, and specific risk assessment for oral cancer... more

MORE ABOUT VIGILANT'S ONCALERT™ TECHNOLOGY

News + Press

  • logo

    Want to Save Lives? Detect Oral Cancer EARLY!

    Did you know that early diagnosis of oral cancer can more than double a patient’s chances of survival?  What if a simple oral rinse could help determine if your patients are at risk for oral cancer?  We could save countless…more

  • Screen Shot 2015-02-26 at 2.21.42 PM

    Developer of oral cancer testing system motivated by parents’ disease

    They say necessity is the mother of invention. But for Matthew H.J. Kim, founder and CEO of Vigilant Biosciences, the motivation for developing the OncAlert oral cancer detection system was seeing the ordeal his parents went through with the disease….more

  • dental_products_report

    Vigilant Biosciences debuts OncAlert Oral Cancer Risk Assessment System at IDS 2015

    Vigilant Biosciences, Inc., a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, debuted its OncAlert Oral Cancer Risk Assessment System in Hall 4.2 Booth #N049 at theInternational Dental Show (IDS) 2015, the…more

  • Screen Shot 2015-02-26 at 2.21.42 PM

    Vigilant debuts OncAlert system at IDS, signs distribution deals

    March 11, 2015 — Vigilant Biosciences is debuting its OncAlert oral cancer risk assessment system at this week’s International Dental Show (IDS) in Cologne, Germany. The system includes the OncAlert rapid, point-of-care (POC) risk assessment test, OncAlert POC Test, and…more


©2011-2015 Vigilant Biosciences, Inc. All Rights Reserved.

×